Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/23973
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kelly, P. | - |
dc.contributor.author | Ardian, M. | - |
dc.contributor.author | Waramori, G. | - |
dc.contributor.author | Anstey, N. | - |
dc.contributor.author | Syahrial, H. | - |
dc.contributor.author | Tjitra, E. | - |
dc.contributor.author | Bastian, I. | - |
dc.contributor.author | Maguire, G. | - |
dc.contributor.author | Lumb, R. | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | International Journal of Tuberculosis and Lung Disease, 2006; 10(2):167-171 | - |
dc.identifier.issn | 1027-3719 | - |
dc.identifier.issn | 1815-7920 | - |
dc.identifier.uri | http://hdl.handle.net/2440/23973 | - |
dc.description.abstract | SETTING: A district level tuberculosis (TB) control programme in Papua Province, Indonesia. OBJECTIVE: To determine the nature and extent of drug-resistant TB in newly diagnosed sputum smear-positive patients. METHODS: Sputum was collected from previously untreated smear-positive pulmonary TB patients diagnosed in the district over a 10-month period. Sputum specimens were processed and inoculated into a BACTEC MGIT960 tube. Isolates were identified by Ziehl-Neelsen staining, hybridisation with nucleic acid probes and biochemical investigations. Susceptibility testing was performed using the radiometric proportion method. Pyrazinamide testing was performed using the Wayne indirect method. RESULTS: One hundred and seven patients had sputum sent to a reference laboratory; 101 (94.4%) were culture-positive for Mycobacterium tuberculosis, with 87 (86.1%) fully sensitive to first-line anti-tuberculosis drugs. Two per cent were multidrug-resistant (MDR-TB) and 12 (11.9%) had other drug resistance. Each of the MDR-TB isolates was susceptible to amikacin, capreomycin, ciprofloxacin and para-aminosalicylic acid (PAS), but were resistant to rifabutin. One isolate was also resistant to ethionamide. CONCLUSIONS: MDR-TB is present in Indonesia but is not a major problem for TB control in this district. Generalisability to other districts in Indonesia, particularly large urban areas, needs to be confirmed by future studies. | - |
dc.description.statementofresponsibility | P. M. Kelly, M. Ardian, G. Waramori, N. M. Anstey, H. Syahrial, E. Tjitra, I. Bastian, G. P. Maguire, R. Lumb | - |
dc.language.iso | en | - |
dc.publisher | Int Union Against Tuberculosis Lung Disease (i U A T L D) | - |
dc.rights | © 2006 Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article | - |
dc.source.uri | http://adelaideaus.library.ingentaconnect.com/content/iuatld/ijtld/2006/00000010/00000002/art00009 | - |
dc.subject | tuberculosis | - |
dc.subject | Indonesia | - |
dc.subject | multi-drug resistance | - |
dc.subject | epidemiology | - |
dc.subject | survey | - |
dc.title | A community-based TB drug susceptibility study in Mimika district, Papua province, Indonesia | - |
dc.type | Journal article | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest 2 Molecular and Biomedical Science publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.